title: Results of treatment of imminent premature labour with the preparation Salbupart-POLFA.
abstract: The preparation Salbupart POLFA was used in 40 pregnant women in the treatment of imminent premature labour. The tocolytic effect of the drug was confirmed, especially in pregnancy over 32 weeks. The observed side effects, mainly in the cardiovascular system, did not require drug withdrawal, but tended towards the necessity of using symptom-alleviating drugs such as Isoptin.
authors.forename: J
authors.initials: J
authors.lastname: Woytoń
authors.forename: M
authors.initials: M
authors.lastname: Gabryś
authors.forename: M
authors.initials: M
authors.lastname: Geneja
authors.forename: J
authors.initials: J
authors.lastname: Florjański
mesh_terms: D000328:Adult; D000420:Albuterol / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use; D006801:Humans; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D015149:Tocolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D015149:Tocolytic Agents; C063798:Salbupart; D005280:Fenoterol; D000420:Albuterol